Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

Summary of Significant Segment Expenses

Significant segment expenses are presented below.


		Three Months Ended June 30,								Six Months Ended June 30,
		2025				2024				2025				2024
		(in thousands)								(in thousands)
Clinical, Preclinical, and R&D Operations (1)		$	(16,811	)		$	(12,123	)		$	(33,197	)		$	(23,623	)
Chemistry, Manufacturing, and Controls (1)			(6,071	)			(4,756	)			(13,028	)			(10,309	)
General and Administrative (1)			(5,731	)			(5,883	)			(11,423	)			(11,145	)
Other Segment Items (2)			1,594				2,425				3,146				5,034
Net loss		$	(27,019	)		$	(20,337	)		$	(54,502	)		$	(40,043	)

(1) Includes depreciation expense directly allocated to respective activities.

(2) Other segment items primarily include interest and accretion income, realized gains and losses, and income taxes.